Serum Institute's multivalent meningococcal meningitis vaccine gets WHO prequalification
The Serum Institute of India (SII), world's largest vaccine maker by volumes on Wednesday said its vaccine to protect against the five predominant causes of meningococcal meningitis in Africa has been prequalified by the World Health Organisation (WHO), making the vaccine eligible to be procured by United Nations agencies and Gavi, the Vaccine Alliance.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
